Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update.

Saved in:
Bibliographic Details
Title: Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update.
Authors: Patel PJ; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK., Devonport H; The Ophthalmology Department, Bradford Royal Infirmary, Bradford, UK., Sivaprasad S; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK., Ross AH; The Ophthalmology Department, Bristol Eye Hospital, Bristol, UK., Walters G; Department of Ophthalmology, Harrogate District Hospital, Harrogate, UK., Gale RP; The Ophthalmology Department, The York Hospital and Department of Health Sciences, University of York, York, UK., Lotery AJ; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Mahmood S; Manchester Royal Eye Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Talks JS; Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK., Napier J; Medical Affairs, Bayer plc, Reading, Berkshire, UK.
Source: Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2017 Nov 06; Vol. 11, pp. 1957-1966. Date of Electronic Publication: 2017 Nov 06 (Print Publication: 2017).
Publication Type: Editorial
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101321512 Publication Model: eCollection Cited Medium: Print ISSN: 1177-5467 (Print) Linking ISSN: 11775467 NLM ISO Abbreviation: Clin Ophthalmol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1177-5467
DOI:10.2147/OPTH.S145732